NDA 17422, held by Avet Lifesciences. Carmustine.
As of Nov 14, 2026, NDA 17422 (Bicnu), held by Avet Lifesciences, was first approved by FDA on Mar 7, 1977, with 42 approved supplements and 0 published complete response letters.
Carmustine for Injection, USP is a nitrosourea indicated as palliative therapy as a single agent or in established combination therapy with other approved chemotherapeutic agents in the following: Brain tumors glioblastoma, brainstem glioma, medulloblastoma, astrocytoma, ependymoma, and metastatic brain tumors Multiple myeloma-in combination with prednisone Relapsed or refractory Hodgkin's lymphoma in combination with other approved drugs Relapsed or refractory Non-Hodgkin's lymphomas in combination with other approved drugs
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 7, 1977 | Original applicationNew molecular entity · Standard review | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Bicnu100MG/VIAL · injectable;injection | Carmustine | RxReference drug |
| Apr 30, 2021 | Supplement 62Manufacturing | Approved | |
| Mar 24, 2017 | Supplement 55Labeling · Standard review | Approved | |
| Apr 28, 2016 | Supplement 50Labeling · Standard review | Approved | |
| Nov 25, 2015 | Supplement 49Manufacturing · Standard review | Approved | None posted |
| Jun 13, 2014 | Supplement 47Manufacturing · Standard review | Approved | |
| Oct 18, 2013 | Supplement 46Labeling · Standard review | Approved | |
| Sep 18, 2013 | Supplement 45Manufacturing · Standard review | Approved | |
| Aug 11, 2011 | Supplement 42Labeling · Standard review | Approved | |
| Mar 14, 2011 | Supplement 38Labeling · Standard review | Approved | |
| Aug 17, 2007 | Supplement 37Manufacturing | Approved | |
| Oct 20, 2005 | Supplement 36Manufacturing · Standard review | Approved | |
| Feb 27, 2003 | Supplement 35Labeling · Standard review | Approved | |
| Sep 10, 1997 | Supplement 34Labeling · Standard review | Approved | None posted |
| Dec 11, 1992 | Supplement 31Labeling | Approved | None posted |
| Jul 13, 1992 | Supplement 32Manufacturing · Standard review | Approved | None posted |
| Jun 13, 1991 | Supplement 29Manufacturing · Standard review | Approved | None posted |
| Jan 3, 1991 | Supplement 28Manufacturing · Standard review | Approved | None posted |
| Sep 14, 1989 | Supplement 27Manufacturing · Standard review | Approved | None posted |
| Apr 19, 1989 | Supplement 25Manufacturing · Standard review | Approved | None posted |
| May 17, 1988 | Supplement 24Manufacturing · Standard review | Approved | None posted |
| Jan 12, 1988 | Supplement 23Manufacturing · Standard review | Approved | None posted |
| Oct 26, 1987 | Supplement 22Labeling | Approved | None posted |
| Aug 7, 1987 | Supplement 20Manufacturing · Standard review | Approved | None posted |
| Apr 21, 1987 | Supplement 8Labeling | Approved | None posted |
| Mar 5, 1987 | Supplement 19Manufacturing · Standard review | Approved | None posted |
| Jul 11, 1986 | Supplement 15Labeling | Approved | None posted |
| May 19, 1986 | Supplement 18Labeling | Approved | None posted |
| May 19, 1986 | Supplement 17Labeling | Approved | None posted |
| May 19, 1986 | Supplement 16Labeling | Approved | None posted |
| Dec 10, 1984 | Supplement 14Manufacturing · Standard review | Approved | None posted |
| Aug 8, 1984 | Supplement 13Manufacturing · Standard review | Approved | None posted |
| Apr 3, 1984 | Supplement 6Manufacturing · Standard review | Approved | None posted |
| Mar 13, 1984 | Supplement 12Manufacturing · Standard review | Approved | None posted |
| Feb 17, 1984 | Supplement 10Manufacturing · Standard review | Approved | None posted |
| Jun 29, 1983 | Supplement 11Labeling | Approved | None posted |
| Feb 10, 1983 | Supplement 9Manufacturing · Standard review | Approved | None posted |
| Feb 16, 1982 | Supplement 7Labeling | Approved | None posted |
| Nov 12, 1980 | Supplement 5Labeling | Approved | None posted |
| Oct 9, 1979 | Supplement 4Labeling | Approved | None posted |
| Oct 9, 1979 | Supplement 3Manufacturing · Standard review | Approved | None posted |
| Sep 15, 1978 | Supplement 2Manufacturing · Standard review | Approved | None posted |
| Dec 22, 1977 | Supplement 1Labeling | Approved | None posted |
| Mar 7, 1977 | Original applicationNew molecular entity · Standard review | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters